GHRL and Abdominal obesity: Our findings are indeed in accordance with a previous study showing that obestatin was significantly lower in centrally obese, hypertensive individuals compared with those with central obesity alone (19).The observed interaction between hypertension and central obesity in this study suggested that hypertension and central obesity may confer opposing effects on obestatin.